GPT-5.4 Produces a Validated Experimental Result in Drug Discovery — Not Just a Literature Review
OpenAI says GPT-5.4 drove a medicinal chemistry project from literature review through to a validated experimental result in partnership with Molecule.one, crossing the line from AI-as-research-assistant to AI-as-lab-contributor.
OpenAI published results showing GPT-5.4 contributed to a medicinal chemistry project that produced a validated experimental result, not merely a hypothesis or literature synthesis. As @OpenAI described in a post that drew over 2,000 likes and 266,000 views, the model worked in partnership with Molecule.one to move a project from initial literature review through to experimental validation — including identifying reaction improvements that apparently surprised the human chemists involved.
Unlock the full briefing
Get every story in today's briefing, the full archive, and the daily AI intelligence brief.
All stories today
Full archive
Daily brief
Cancel anytime. Payments powered by Stripe.